According to Fortune Business Insights the global xenon market size was valued at USD 253.14 million in 2023 and is projected to grow from USD 258.74 million in 2024 to USD 304.74 million by 2032, exhibiting a CAGR of 2.1% during the forecast period. Xenon (Xe) is the most commonly utilized propellant, because it has high atomic mass and is easily ionized, thus delivering the necessary amount of thrust when ions are accelerated. Moreover, the gas is inert and has high storage density and therefore, it is ideal for storing in a spacecraft. Its favorable properties for space missions have encouraged space agencies to develop technologies that can efficiently leverage the powers of xenon. For example, the National Aeronautics and Space Administration (NASA) has been developing the NASA Evolutionary Xenon Thruster (NEXT), which is a high-power ion propulsion system engineered to reduce mission trip time and cost.
Get a Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/sample/xenon-market-101965
Market Segmentation
The market is categorized on the basis of type, application, and geography. In terms of type, it is divided into N3, N4.5, and N5. Based on the application, it is fragmented into imaging and lighting, satellite, electronics & semiconductors, medical, and others. On the basis of region, it is segmented into North America, Europe, South America, Asia Pacific, and the Middle East & Africa.
List of Key Companies Covered in this Market Report:
Market Restraint
Potential Health Risks of Xenon May Inhibit Adoption in the Medical Industry
A prominent constraint facing the xenon market growth is the health risks associated with the inhalation of the gas. Xe has been classified as a simple asphyxiant and intake of the gas in high concentrations can lead to nausea, vomiting, dizziness, and even death. If oxygen levels are low, unconsciousness or death can occur in a matter of minutes without warning. The immediate symptoms indicating the excessive inhalation of a simple asphyxiant include rapid respirations and want of air. Low oxygen supply to the brain then leads to diminishing of mental alertness and impairment of muscular coordination. Senses are suppressed and as the effects intensify, the person loses consciousness, slips into coma, and eventually, death. The health hazards linked to xenon are, therefore, impeding the adoption of the gas in the healthcare industry. However, despite its drawbacks, Xe is widely used in small proportions for its natural anesthetic properties in the healthcare facilities to effectively perform surgical procedures.
Regional Insights